![](https://www.aptitudehealth.com/wp-content/uploads/2021/08/Cancer-Cell-01-Mobile.jpg)
Management of TKI Therapies in Integrated Delivery Network (IDN) Pharmacies
Perspectives on drivers in treatment decisions in the management of hepatocellular carcinoma/renal cell carcinoma (HCC/RCC)
![](https://www.aptitudehealth.com/wp-content/uploads/2022/04/Bhavesh-Shah-RPh-BCOP-Aptitude-Health.jpg)
Faculty Chair
Bhavesh Shah, RPh, BCOP
Boston Medical Center
More Information
- Virtual series
- The group of advisors comprised 16 clinical pharmacists, nurse practitioners, and/or pharmacy managers from 11 states across the US
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on current treatment practices and future considerations for treatment of RCC and HCC
- Insights on the following therapies were obtained
- Management of TKI therapies in solid tumors
- Patient management within IDN pharmacies
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 16 clinical pharmacists, nurse practitioners, and/or pharmacy managers from 11 states across the US